Advanced Biomed Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Advanced Biomed Inc. (ADVB) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec 2025Jun 2024Jun 2023Jun 2022Jun 2021
Operating Activities
Net Income-0.10-2.78-3.73-4.03-1.84
Depreciation & Amortization0.010.400.230.110.06
Change in Working Capital-0.090.260.251.501.31
Change in Accounts Payable0.000.480.380.910.02
Change in Other Working Capital-0.09-0.05-0.130.591.29
Other Operating Activities0.00-0.05-0.020.000.00
Net Cash from Operating Activities-0.18-2.13-2.96-0.74-0.47
Investing Activities
Capital Expenditures0.00-0.07-0.21-0.89-0.03
Acquisitions0.000.00-0.050.200.00
Sales/Maturities of Investments0.000.000.00-0.420.00
Net Cash from Investing Activities0.00-0.07-0.26-1.08-0.03
Financing Activities
Debt Repayment0.010.000.000.000.00
Common Stock Issued0.170.001.016.100.70
Other Financing Activities0.000.29-0.550.000.00
Net Cash from Financing Activities0.181.870.466.100.70
Summary
Effect of Forex Changes on Cash0.020.320.610.45-0.20
Net Change in Cash0.02-0.33-2.164.720.00
Cash at Beginning of Period0.082.624.780.070.07
Cash at End of Period0.102.612.624.780.07
Free Cash Flow-0.18-2.20-3.17-1.63-0.50